Combined Immunotherapy and Chemotherapy for Muscle-invasive Bladder Cancer

Trial ID:
IRB-19-7391
Munveer S Bhangoo, MD
A global study to evaluate peri-operative pembrolizumab with chemotherapy versus placebo to pembrolizumab plus chemotherapy in cisplatin eligible patients.
* Be 18 years of age or older<br>* Have a confirmed diagnosis of Muscle – invasive Bladder Cancer (MIBC), Clinical Stage T2-T4aN0M0<br>* Be eligible to receive cisplatin chemotherapy.<br>* Be eligible for surgical treatment and agree to planned surgical treatment

Contact Info:

  • Clinical Research Services
  • CRSLeadership@scrippshealth.org

Why isn't this trial accepting new patients?

The trial may have a limited enrollment number, reached its maximum, or come to the end of its enrollment period. View trials that are recruiting

How else can Scripps help me?

We have a broad range of physician expertise and specialized medical services available. You can find a doctor online, call 1-800-SCRIPPS (1-800-727-4777) for personal help, or see related Scripps services.

How can I find trials that are accepting new participants?

For more information, see a list of trials that are recruiting, or call the clinical research office at 858-648-6402 for help.